Johns Hopkins Study of Psilocybin in Cancer Patients

Investigators: Roland Griffiths PhD, William Richards PhD, Matthew Johnson, Ph.D., Una McCann, M.D. Sponsor: Heffter Research Institute, Riverstyx Foundation Contact: Roland Griffiths, PhD Status: Completed …

Psilocybin: Basic Dose-Response Safety Studies

Investigator: Franz Vollenweider, MD Psychiatric University Hospital Zurich, Switzerland Contact: Sponsor: Heffter Dr. Vollenweider’s team have completed a series of basic research studies into the …

The Concord Prison Experiment Experiment Follow-Up

Investigator: Rick Doblin, Ph.D. This study, originally published in the Journal of Psychoactive Drugs [Oct-Dec 1998] is one in a series of long-term follow-ups to early psychedelic research that MAPS …

Human Psychopharmacology of Psilocybin

Investigator: Rick Strassman, MD University of New Mexico, USA Psychobiological study. Phase 1 dose-response study Sponsor: NIDA Begun, not completed due to personal reasons unrelated to study itself. …

Psilocybin’s Effects on Cognition

Investigator: Manfred Spitzer, MD, PhD et al. Psychiatrische Universitats Klinic, Heidelberg, Germany Human clinical study, completed and published. More psilocybin research in Germany Spitzer M, et al. …

Human Psychopharmacology of Psilocybin

Investigator: Rick Strassman, MD University of New Mexico, USA Psychobiological study. Phase 1 dose-response study Sponsor: NIDA Begun, not completed due to personal reasons unrelated to study itself. …

Psilocybin in the Treatment of Cancer Patients

Investigator: Charles Grob, MD, UCLA-Harbor Medical Center – Torrance, CA Contact: cgrob at labiomed.org Web: JAMA Psychiatry Sponsor: Heffter Grob has prepared a study investigating whether anxiety …